Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2025-04-30 AGM Information
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting 2025
AGM Information Classification · 100% confidence The document is explicitly titled 'INNKALLING TIL ORDINÆR GENERALFORSAMLING' (Notice of Annual General Meeting) in Norwegian. It details the date, time, location, and a numbered agenda for the meeting, which includes items typical for an AGM such as approving the annual report, electing the board, and approving remuneration. The document also includes forms for registration and proxy voting. This content directly corresponds to the definition of AGM Information.
2025-04-30 Norwegian
Notice of Annual General Meeting 2025
AGM Information Classification · 99% confidence The document is explicitly titled "PROPOSED RESOLUTIONS FOR THE ANNUAL GENERAL MEETING 22 May 2025". It details specific items to be voted upon at this meeting, such as the election of the chairperson, approval of accounts, election of the board, determination of remuneration, and authorizations for capital increases. These materials, which outline proposals to be presented and voted on at an AGM, fit the definition of AGM Information (AGM-R). Although it mentions the approval of the annual report (Item 5), the document itself is the set of proposed resolutions for the meeting, not the full Annual Report (10-K) or the final voting results (DVA).
2025-04-30 English
Notice of Annual General Meeting 2025
AGM Information Classification · 99% confidence The document is explicitly titled "NOTICE OF ANNUAL GENERAL MEETING OF PCI BIOTECH HOLDING ASA". It details the date, time, location, agenda items (including approval of annual accounts, election of the board, and remuneration votes), and procedures for shareholder attendance and proxy voting. This content perfectly matches the definition of an AGM notice/material, which corresponds to the 'AGM-R' (AGM Information) code. Although it mentions the approval of the annual report (Item 5), the document itself is the notice convening the meeting, not the full annual report (10-K) or a general earnings release (ER).
2025-04-30 English
Notice of Annual General Meeting 2025
AGM Information Classification · 98% confidence The document is explicitly titled 'Notice of Annual General Meeting 2025' and provides the date, time, and location for the AGM. It states that the 'notice and proposed resolutions' are attached and will be made available on the corporate website. Since this is a short notice document announcing the meeting and its associated materials, rather than the full presentation or voting results, it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the AGM. Although it is a notice, the content is directly about the AGM event itself.
2025-04-30 English
PCI Biotech Holding ASA: Annual Report 2024
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-04-24 English
PCI Biotech Holding ASA: Annual Report 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT' and contains standard sections such as the Board of Directors report, financial statements, and auditor's report for PCI Biotech Holding ASA for the fiscal year 2024. It is a comprehensive document detailing company activity and performance, fitting the definition of a 10-K (Annual Report). FY 2024
2025-04-24 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.